Şengül Özdek

Şengül Özdek

Auto-generated profile, based on publicly available information

Şengül Özdek

Department of Ophthalmology, Gazi University School of Medicine, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2013 in Eye
Verified
Journal Article
Closed access
SOS Ozdek
S Ozdek
MHMurat Hasanreisoglu
Murat Hasanreisoglu
EYE Yuksel
E Yuksel

7 December 2021 in Acta Ophthalmologica
Verified
Journal Article
Closed access
PDF file
MIMariano Iros
Mariano Iros
Barbara ParoliniBarbara Parolini
Barbara Parolini
SOSengul Ozdek
Sengul Ozdek
GGGiampaolo Gini
Giampaolo Gini
ZNZofia Anna Nawrocka
Zofia Anna Nawrocka
ZMZofia Michalewska
Zofia Michalewska

1 October 2019 in Turkish Journal of Ophthalmology
Verified
Journal Article
Closed access
MHMurat Hasanreisoglu
Murat Hasanreisoglu
HOHuseyin Baran Ozdemir
Huseyin Baran Ozdemir
KÖKaan Özkan
Kaan Özkan
MYMurat Yüksel
Murat Yüksel
ZAZeynep Aktaş
Zeynep Aktaş
GGGökhan Gürelik
Gökhan Gürelik
To evaluate the long-term results of intravitreal dexamethasone implant (DEX) for noninfectious uveitis. The study included 62 eyes of 44 patients treated with DEX implant due to noninfectious uveitis and followed up for at least a year. Best-corrected visual acuity (BCVA), central foveal thickness, intraocular pressure (IOP), vitreous haze score, indications, immunomodulatory therapy and steroid usage before/after injection, number of injections, and adverse events were analyzed retrospectively. Average follow-up was 20 months (range 12-64 months). The female/male ratio was 29/15. Mean age was 50 years (range 22-75 years). The most frequent uveitis etiologies were idiopathic (25 patients, 40.3%) and Behçet’s uveitis. (17 patients, 27.4%) The most common indication for DEX injection was cystoid macular edema together with resistant vitreous haze (26 eyes, 41.9%). Twenty-two eyes (30%) received more than one DEX injection. Mean BCVA was improved from 0.55 logMAR at baseline to 0.38, 0.32, and 0.35 after 1, 3, and 6 months, respectively (p<0.001 for each). Mean CFT was decreased from 386 μm at baseline to 288, 311, and 302 μm after 1, 3, and 6 months, respectively (p<0.001 for each). Mean IOP did not change significantly during follow-up. Five eyes (8%) received topical anti-glaucoma medication (IOP ≥25 mmHg). Eighteen (46%) of 39 phakic eyes underwent cataract surgery during follow-up. Similar efficacy of the DEX implant was observed in eyes that received multiple injections. Systemic immunomodulatory therapy did not change significantly during follow-up. Intravitreal DEX injection does not alter systemic immunomodulatory therapy, but may facilitate the management of noninfectious uveitis by suppressing local intraocular inflammation. Multiple injections yielded comparable visual and anatomical outcomes to single injections. Follow-up for ocular hypertension and cataract formation are important, especially in eyes receiving multiple injections.

1 August 2019 in Turkish Journal of Ophthalmology
Verified
Journal Article
Open access
NYNuriye Gökçen Yalçın
Nuriye Gökçen Yalçın
ŞÖŞengül Özdek
Şengül Özdek
To evaluate the relationship between cyst characteristics and macular and peripheral ischemia in diabetic macular edema (DME). We retrospectively reviewed eyes with DME and included those with clinically significant macular edema as defined by ETDRS (Early Treatment Diabetic Retinopathy Study) and cystoid spaces in optical coherence tomography scans in this study. Central subfield thickness (CSFT), horizontal and vertical diameters of the largest cyst, cyst area, and the remaining retinal thickness outside the cyst were determined. The presence and number of hyperreflective foci in the cyst wall and the internal reflectivity of the cyst were analyzed. Outer retinal damage was graded. Fluorescein angiography was used to determine the areas of macular and peripheral ischemia, which were graded as mild or severe. Correlations between macular and peripheral ischemia and cyst-related measurements and structural changes in the retina were evaluated. This retrospective study included 250 eyes of 186 patients with DME. Mean CSFT was significantly greater in eyes with macular ischemia (510.4±144.7 μm) compared to eyes without macular ischemia (452.1±114.6 μm) (p=0.001). Horizontal and vertical diameter of the largest cyst increased with the presence and severity of macular ischemia (p=0.045 and p=0.016, respectively). Remaining retinal thickness increased with the presence and severity of peripheral ischemia (p=0.009). There was a statistically significant relationship between the number of the hyperreflective foci in the cyst wall and internal reflectivity of the cyst (p=0.007). Patients with greater CSFT had a 1.04-times higher odds of having macular ischemia and 0.25-times higher odds of having outer retinal damage. The likelihood of macular ischemia increases with larger cyst diameter, CSFT, and extent of outer retinal damage. Thickness of the noncystic area is increased in the presence of peripheral ischemia.

14 October 2022 in Saudi Journal of Ophthalmology
Verified
Journal Article
Open access
HÖHuseyin B. Özdemir
Huseyin B. Özdemir
SÖSengül Özdek
Sengül Özdek
This article provides information about late complications of retinopathy of prematurity (ROP), especially seen in adolescence and adulthood. The majority of ROP patients recover without complications and treatment, but severe ROP cases should be properly treated. Both prematurity itself and the treatment of ROP cause some changes in the anterior (refractive changes, cataract, and glaucoma) and posterior segments (tractional, rhegmatogenous and exudative retinal detachment, vitreous hemorrhage, etc.,) of the eye and predispose to significant lifelong complications. Awareness of these late complications can minimize severe vision loss with proper follow-up and appropriate treatment. Therefore, life-long ophthalmological follow-up is mandatory in all prematures with the diagnosis of ROP.

1 February 2023 in Turkish Journal of Ophthalmology
Verified
Journal Article
Closed access
ŞÖŞengül Özdek
Şengül Özdek
EZEce Özdemir Zeydanlı
Ece Özdemir Zeydanlı
CBCaroline Baumal
Caroline Baumal
SHSandra Hoyek
Sandra Hoyek
NPNimesh Patel
Nimesh Patel
SASolmaz Akar
Solmaz Akar
Avascular peripheral retina in an infant is a common characteristic of numerous pediatric retinal vascular disorders and often presents a diagnostic challenge to the clinician. In this review, key features of each disease in the differential diagnosis, from retinopathy of prematurity, familial exudative vitreoretinopathy, Coats disease, incontinentia pigmenti, Norrie disease, and persistent fetal vasculature, to other rare hematologic conditions and telomere disorders, will be discussed by expert ophthalmologists in the field.